ArticleHeliyon2024

NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.

Dániel Sandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.